CHCT logo

COMMUNITY HEALTHCARE TRUST I

CHCTNYSE
πŸ† #2774 by market capEarnings Oct 27US Equity
$14.89β–Ό $0.18 (βˆ’1.19%)
Live
1hβ€”
24hβ–Ό 1.2%
7dβ–Ό 3.2%
14dβ–Ό 20.5%
30dβ–Ό 17.6%
1yβ–² 0.9%
🏦Market Cap
$425M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+4.7%
Slowing
πŸ“ŠGross Margin
63.1%
High
πŸ’΅FCF Margin
47.7%
Strong
βš–οΈP/S Ratio
3.5x
Fair
Otter Score
42
Weak

Trading Snapshot

Day Range
$14.81 – $15.06
52-Week Range
$13.23 – $19.17
Volume
$2.46B
Avg Volume
$3.23B
Shares Outstanding
28.6M
Next Earnings
Oct 13, 2026

Fundamentals Snapshot

Annual Revenue
$121M
Last Q Revenue
$31M
P/E Ratio
22.4
P/S Ratio
3.5x
EPS (TTM)
$0.78
Dividend Yield
12.64%

Why Investors Own CHCT

  • βœ“High-growth profile β€” revenue up +49.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 39% gross margin and 22% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$121Mβ–² +43.9% YoY
Gross Margin (TTM)
39.4%β–² +0.2% YoY
Operating Income (TTM)
$32Mβ–² +43.9% YoY
Free Cash Flow (TTM)
$26Mβ–² +43.9% YoY

About COMMUNITY HEALTHCARE TRUST I

Community Healthcare Trust Incorporated is a real estate investment trust. It focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of December 31, 2025, the Company had investments of approximately 1.2 billion US dollars in 198 real estate properties (including one property with sales-type leases and one property classified as held for sale). The properties are in 36 states, totaling approximately 4.5 million square feet in the aggregate. Community Healthcare Trust Incorporated was incorporated in 2014 in Maryland, USA.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
42/100

Analyst Ratings

β“˜
Consensus
Buy
11 analysts
Strong Buy3
Buy5
Hold3
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates